RE:RE:RE:RE:RE:RE:ADCOM lineIf all goes well and according to plan we will sell our manufacturing capacity just before demand materializes. In a stroke of genius the vaccine plant will be sold for one dollar plus assumption of debt to our new contract manufacturer.
We will then contract out manufacturing for 110% of the selling price plus bonuses for meeting production targets. But thats okay because we will have the money for new indications for an aging population. For example, we might corner the Depends market. And, MCNA might be just dandy for toenail fungus.
I hope this helps. Feel free to ask me more questions if you haven't strung yourself up on a rope in the meantime.